The Company held the Sixth Meeting of the Third Session of the Board of Directors on June 25, 2023, and considered and passed the "Proposal on Appointment of the Secretary of the Board of Directors of the Company".

The 2022 annual equity distribution plan of Zhuhai Keyu Biological Engineering Company Limited has been considered and approved by the shareholders' meeting held on May 12, 2023, and is hereby announced as follows. The equity distribution plan for the year 2022 has been considered and approved by the general meeting of shareholders held on May 12, 2023, and is hereby announced as follows: Undistributed profit attributable to the parent company in the consolidated statement as at the base date of this equity distribution amounted to RMB45,131,082.50, and undistributed profit of the parent company amounted to RMB47,082.50. The undistributed profit attributable to the parent company in the consolidated statement on the base date of this equity distribution was RMB45,131,082.50 and the undistributed profit of the parent company was RMB47,674,651.75. The total cash dividends distributed in this equity distribution are as follows 10,206,000.00 Yuan.

Zhuhai Keyu Biological Engineering Co., Ltd. at the fifth meeting of the third session of the Board of Directors and the fourth meeting of the third session of the Supervisory Committee held on April 8, 2023, considered and approved the "Annual Report for the Year 2022". (hereinafter referred to as the "Company") was held on 8 April 2023, the Fifth Meeting of the Third Session of the Board of Directors and the Fourth Meeting of the Third Session of the Supervisory Committee considered and passed the On April 10, 2023, the ''Announcement on the 2022 Annual Profit Distribution Proposal'' was disclosed on the designated information platform of the National Small and Medium Enterprises Stock Transfer System (www.neeq.com.cn) (Announcement (Announcement No.: 2023-023), the details of the profit distribution plan are as follows.

Zhuhai Keyu Biological Engineering Co., Ltd. disclosed the "Announcement on Restricted Share Grant under Share Incentive Plan" (Announcement No. 2023-036) on May 5, 2023 on the information disclosure designated by National Small and Medium-sized Enterprises Stock Transfer System (www.neeq.com.cn). (Announcement No. 2023-036) on the information disclosure platform designated by the National Small and Medium Enterprises Stock Transfer System () on 5 May 2023, in which it disclosed the "Announcement of Restricted Share Award under the Share Incentive Scheme" (Announcement No. 2023-036), which stipulated the restricted share award in "V. Payment Arrangement". The "Announcement of Restricted Share Grant under Share Incentive Scheme" (Announcement No. 2023-036) was disclosed on the information disclosure platform designated by the National Small and Medium Enterprises Stock Transfer System (), in which it was stipulated in "V. Payment Arrangement" that the subscription and payment dates for the Restricted Shares would be from 5 May 2023 to 19 May 2023.

On March 13, 2023, Zhuhai Keyu Biological Engineering CO., Ltd. held the fourth meeting of the third session of the Board of Directors and the second meeting of the third session of the Board of Supervisors. (hereinafter referred to as the "Company") held the fourth meeting of the third session of the Board of Directors and the second meeting of the third session of the Supervisory Committee on March 13, 2023, at which the "Proposal on the Share Incentive Plan (Draft) of KEYU Share Incentive Plan (Draft) of KEYU and on March 15, 2023 On March 15, 2023, it disclosed on the information disclosure platform designated by the National Small and Medium-sized Enterprises Stock Transfer System (www.neeq.com.cn) the Share Incentive Scheme (Draft) (Announcement No. 2023-007).

On March 13, 2023, Zhuhai Keyu Biological Engineering Co., Ltd. held the fourth meeting of the third session of the Board of Directors and the second meeting of the third session of the Board of Supervisors. (hereinafter referred to as the "Company") held the fourth meeting of the third session of the Board of Directors and the second meeting of the third session of the Supervisory Committee on March 13, 2023, at which the "Proposal on the Share Incentive Plan (Draft) of Zhuhai Keyu Share Incentive Plan (Draft) of Zhuhai Keyu Biological Engineering Co. (the "Company") and on March 15, 2023 On March 15, 2023, it disclosed on the information disclosure platform designated by the National Small and Medium-sized Enterprises Stock Transfer System (www.neeq.com.cn) the Share Incentive Scheme (Draft) (Announcement No. 2023-007).

According to the Company's 2022 annual report disclosed on April 10, 2023, as of December 31, 2022 As of December 31, 2022, the undistributed earnings attributable to the parent company in the consolidated statements of the listed company were 45,131,082.50, and the parent company's The undistributed earnings of the listed company attributable to the parent company in the consolidated statement as of December 31, 2022 was RMB45,131,082.50 and the undistributed earnings of the parent company was RMB47,674,651.75.

In accordance with the Measures for the Supervision and Administration of Unlisted Public Companies, the Rules for Directed Issuance of Stocks in the National Small and Medium-sized Enterprise Stock Transfer System, the Business Guidelines for Directed Issuance of Stocks in the National Small and Medium-sized Enterprise Stock Transfer System and other relevant laws and regulations. Rules for Directed Issuance of Stocks in the National Small and Medium-sized Enterprise Stock Transfer System, Business Guidelines for Directed Issuance of Stocks in the National Small and Medium-sized Enterprise Stock Transfer System, and other relevant laws, regulations and standardized documents, the Board of Directors of KEYU conducted a special verification of the deposit and actual utilization of the proceeds for the year 2022, and hereby reports the relevant information as follows. 

Zhuhai KEYU Biological Engineering Company Limited held the Eleventh Meeting of the Second Session of the Board of Directors and the Eighth Meeting of the Second Session of the Board of Supervisors on April 20, 2022 to consider and approve the "Proposal on the Renewal of the Appointment of Audit Institution for the Year of 2022", which was also passed on May 24, 2022 at the 2021 annual general meeting of the Company was passed at the 2021 annual general meeting of the Company on 24 May 2022. For details, please refer to the Company's announcement dated April 20, 2022 on the National Small and Medium-sized Enterprises Stock Transfer System For details, please refer to the ''Announcement on the Proposed Renewal of the Appointment of Accounting Firm by Zhuhai KEYU Biological Engineering Co. Announcement on the Proposed Renewal of the Appointment of Accounting Firm by the Company" (Announcement No. 2022-027). Company Limited held the Eleventh Meeting of the Second Session of the Board of Directors and the Eighth Meeting of the Second Session of the Board of Supervisors on April 20, 2022 to consider and approve the "Proposal on the Renewal of the Appointment of Audit Institution for the Year of 2022", which was also passed on May 24, 2022 at the 2021 annual general meeting of the Company was passed at the 2021 annual general meeting of the Company on 24 May 2022. For details, please refer to the Company's announcement dated April 20, 2022 on the National Small and Medium-sized Enterprises Stock Transfer System For details, please refer to the ''Announcement on the Proposed Renewal of the Appointment of Accounting Firm by KEYU. Announcement on the Proposed Renewal of the Appointment of Accounting Firm by the Company" (Announcement No. 2022-027).